Results 231 to 240 of about 4,670,790 (255)

Development of HIV Drug-Resistance Mutations and Antiretroviral Efficacy Among Vietnamese Patients After Failure of 5-Year First-Line Therapy. [PDF]

J Clin Lab Anal
Hung TM, Bang LVN, Van Duyet L.
europepmc   +1 more source

Analysis of HIV-1 subtypes and drug resistance mutations in people who inject drugs in Aizawl and nearby districts of Mizoram, India. [PDF]

Virulence
Raskar K, Thlengliani L, Lalbiaknunga A, Kale D, Patil A, Chavan P, Hluna RC, Panda S, Kurle S.   +8 more
europepmc   +1 more source

First Reported Case of Integrase Strand Transfer Inhibitor Resistance in Suriname: Unusual Drug Resistance Mutations Following Exposure to Dolutegravir. [PDF]

Viruses
Sno RC, Culbard G, Adhin MR.
europepmc   +1 more source

Prevalence of major INSTI and HIV-1 drug resistance mutations in pre- and antiretroviral-treated patients in Indonesia. [PDF]

Narra J
Djojosugito FA, Arfianti A, Wisaksana R, Siregar FM, Nasronudin N, Rachman BE, Khairunisa SQ, Indrati AR.   +7 more
europepmc   +1 more source

Prevalence and transmission of HIV-1 drug resistance mutations among patients with treatment failure and newly diagnosed people in Liangshan Prefecture, China, in 2021-2023. [PDF]

Front Public Health
Pei R, Zhang Y, Jike C, Yu G, Su L, Wang J, Xiao L, Wang Y, Shen M, Liao J, Zheng Y, Hemelaar J.   +11 more
europepmc   +1 more source

Drug resistance mutations to integrase inhibitors, proteinase, and reverse transcriptase inhibitors in newly diagnosed HIV-1 infections in Hebei province, China, 2018-2022. [PDF]

Front Cell Infect Microbiol
Lu X, Li Y, Liu M, Wang Y, An N, Sun D, Li Q.   +6 more
europepmc   +1 more source

Genomic analysis of Mycobacterium tuberculosis in Thailand reveals circulating lineage diversity, transmission, and drug resistance mutations

Thawong N, Sriloha P, Phelan JE, Phornsiricharoenphant W, Tongsima S, Suriyaphol P, Prammananan T, Faksri K, Sawaengdee W, Wang L, Hinthong W, Hibberd ML, Campino S, Wattanapokayakit S, Mahasirimongkol S, Chaiprasert A, Clark TG.   +16 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Epigenetic enzyme mutations as mediators of anti-cancer drug resistance

Drug Resistance Updates, 2022
Yehuda G Assaraf, Lihui Wang
exaly